Eugenio Fernández

Learn More
A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)
The European Higher Education Area (EHEA), currently under implementation, has forced universities to gradually change all their processes, both teaching and administrative. This has had a great impact on the associated technologies that support those processes. Therefore, the design and definition of all processes related to teaching online must be(More)
MELANOMA BRIDGE 2015 KEYNOTE SPEAKER PRESENTATIONS Molecular and immuno-advances K1 Immunologic and metabolic consequences of PI3K/AKT/mTOR activation in melanoma Vashisht G. Y. Nanda, Weiyi Peng, Patrick Hwu, Michael A. Davies K2 Non-mutational adaptive changes in melanoma cells exposed to BRAF and MEK inhibitors help the establishment of drug resistance(More)
This report presents UCB progress in developing a comprehensive thermal and fluid dynamics model for the NGNP intermediate heat exchanger (IHX) and other compact heat exchangers. For nuclear hydrogen applications, an IHX is required to transfer heat from high temperature and high-pressure primary helium coolant to a hydrogen production process. An(More)
  • 1